Welcome to Bilingual Publishing Group
Bilingual Publishing Group

Unusual Metastases to Diaphragm and Spleen from Adenocarcinoma of Lung Detected by 18F-FDG PET/CT Imaging: A Case Report

Authors

  • Anindita Rani Paul Email Institute of Nuclear medical Physics, AERE, Savar, Dhaka-1349, Bangladesh
  • Rajib Paul Chowdhury Upazila health Complex, Bhuapur, Tangail-1960, Bangladesh
  • Pritam Saha Podder Department of Pharmacy, Jahangirnagar University, Savar-1342, Dhaka, Bangladesh
  • Umme Saoda Institute of Nuclear medical Physics, AERE, Savar, Dhaka-1349, Bangladesh

DOI:

https://doi.org/10.30564/jor.v1i3.1586
Received: 20 December 2019 | Published Online: 17 April 2020

Abstract

Globally, carcinoma of lung is the predominant cause of cancer death
among both men and women. While hematogenous spread from primary
lung cancer to multiple other organs is frequently reported, metastases of
malignant tumors to diaphragm and spleen are rare. Nowadays, Positron
emission tomography (PET) with 18 F- fluorodeoxyglucose (FDG) has
emerged in such a way that it has become an effective imaging technol
ogy for the evaluation of different carcinomas, particularly for cancer
staging and follow up after therapy. PET scan is able to provide metabolic
information. In this case, we present an attractive unified PET/CT scan
image in a patient with lung carcinoma having unusual diaphragm and
splenic metastases. So, PET/CT imaging could strongly identified rare
and unusual metastatic sites of cancer and added more appropriate staging
in patient with carcinoma of lung.

Keywords:

PET/CT, Lung carcinoma, Diaphragm metastasis, Splenic metastasis

References

[1]Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008, 83: 584-594.

[2]Kara PO, Gedik GK, Sarı O, and Özbek O Rare Thyroid Cartilage and Diaphragm Metastases from Lung Cancer Visualized on F-18 FDG-PET/CT Imaging. Mol Imaging Radionucl Ther. 2011 Aug; 20(2): 70–72. DOI: 10.4274/MIRT.019882

[3]Mitsimponas N, Mitsogianni M, Crespo F, Hartmann k-A, Diederich S, Klosterhalfen B et al. Isolated Splenic Metastasis from Non-Small-Cell Lung Cancer: A Case Report and Review of the Literature.Case Rep Oncol.2017;10(2): 638–643. DOI: 10.1159/000478002

[4]Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996, 26(4): 308–314.

[5]Bar-Shalom R, Gaitini D, Keidar Z, Israel O. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging, 2004, 31(8): 1105–1113.

[6]Reck M, Gatzemeier U. Chemotherapy in stage-IV NSCLC. Lung Cancer. 2004, 45(Suppl 2): 217–222.

[7] Niu FY, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer. 2016, 16: 149.DOI: 10.1186/s12885-016-2169-5

Downloads

Issue

2019 Vol.1 No.3

Article Type

Article

License

Copyright © 2020 Anindita Rani Paul, Rajib Paul Chowdhury, Pritam Saha Podder, Umme Saoda

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.